Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Bioengineered ‘mini-colons’ shed light on cancer progression

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 629, 292-293 (2024)



  1. Lorenzo-Martín, L. F. et al. Nature 629, 450–457 (2024).

    Article  Google Scholar 

  2. Hanahan, D. & Weinberg, R. A. Cell 144, 646–674 (2011).

    Article  PubMed  Google Scholar 

  3. Clevers, H. Cell 165, 1586–1597 (2016).

    Article  PubMed  Google Scholar 

  4. Nikolaev, M. et al. Nature 585, 574–578 (2020).

    Article  PubMed  Google Scholar 

  5. Drost, J. et al. Nature 521, 43–47 (2015).

    Article  PubMed  Google Scholar 

  6. Barker, N. et al. Nature 457, 608–611 (2009).

    Article  PubMed  Google Scholar 

  7. Kozar, S. et al. Cell Stem Cell 13, 626–633 (2013).

    Article  PubMed  Google Scholar 

  8. Nicholson, A. M. et al. Cell Stem Cell 22, 909–918 (2018).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

N.R. is employed by Genentech, Inc. and owns shares of Roche. F.d.S.e.M. is an employee of Amgen and owns shares of Roche and Amgen.


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links